doi: 10.1016/j.cell.2017.01.040
Variants in GLP1R, GIPR (the GIP receptor tirzepatide also activates), FTO, MC4R, and TCF7L2 are associated with measurably different response patterns
Are you sure your numbers are correct
Ozempic and Wegovy are clinically effective for body weight loss between three and eight months when used with diet and exercise interventions in overweight adults
According to the World Health Organization (WHO), over 422 million people globally live with diabetes, while obesity has nearly tripled since 1975, with more than 1 billion individuals affected, significantly increasing demand for effective GLP-1-based therapeutic interventions worldwide
Which form suits you is a clinical decision based on your goals, not something to guess at from a forum thread